tirzepatide and vertigo Side Effects Lightheadedness: Causes Management Vertigo and Zepbound: Is Dizziness

Dupont, L

A dedicated phase 2a substudy in people with obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) used MRI to measure liver fat and found that, after 24 weeks, retatrutide reduced relative liver-fat content by about 81% at the 8 mg dose and about 82% at 12 mg, versus essentially no change on placebo

The two premises searched, a farm near Sleaford and a residential address in Grantham, are believed to have been used for the manufacture and distribution of unlicensed weight loss medicines, including retatrutide and tirzepatide, as well as peptide products

Originally developed for type 2 diabetes, clinical trials demonstrated significant weight loss leading to FDA approval for chronic weight management